243 | 0 | 2 |
下载次数 | 被引频次 | 阅读次数 |
目的 探讨抗感方对免疫功能低下小鼠的免疫调节作用及抗H1N1流感病毒作用。方法 采用小鼠网状内皮系统吞噬能力试验(非特异性免疫),小鼠血清溶血素生成试验(体液免疫),小鼠迟发超敏反应试验(细胞免疫),小鼠免疫因子调控试验,观察抗感方对免疫功能低下小鼠的免疫调节作用;采用药物对流感病毒感染BALB/C小鼠死亡的保护实验,观察抗感方抗H1N1流感病毒作用。结果 与模型组比较,各给药组小鼠网状内皮系统吞噬能力有升高的趋势,玉屏风颗粒组(1.95 g/kg)、匹多莫德组(0.21 g/kg)差异有统计学意义(P<0.05或P<0.01)。与模型组比较,各给药组小鼠血清溶血素生成OD值都有升高的趋势,其中抗感方高剂量组(27.30 g生药/kg)、匹多莫德组(0.21 g/kg)升高差异有统计学意义(P<0.05或P<0.01)。与模型组比较,各给药组小鼠迟发超敏反应有下降的趋势,其中抗感方低剂量组(6.82 g生药/kg)、高剂量组(27.30 g生药/kg)、匹多莫德组(0.21 g/kg)降低明显(P<0.05或P<0.01)。与模型对照组比较,抗感方高剂量组(27.30 g生药/kg)、玉屏风颗粒组(1.95 g/kg)、匹多莫德组(0.21 g/kg)能够促进IL-4分泌(P<0.05或P<0.01),抗感方高剂量组(27.30 g生药/kg)、匹多莫德组(0.21 g/kg)能够促进IFN-γ的分泌(P<0.01、P<0.05),抗感方高剂量组(27.30 g生药/kg)能够抑制TNF-α的分泌(P<0.05)。与模型组比较,抗感方中剂量组(13.65 g生药/kg)、奥司他韦胶囊组(19.50 mg/kg)平均生存日数延长(P<0.05或P<0.01)。结论 抗感方具有提高机体免疫力及抗H1N1流感病毒作用,其机制可能与促进IL-4、IFN-γ分泌,抑制TNF-α的生成有关。
Abstract:Objective To investigate the immunoregulatory effect of Kanggan Decoction(抗感方) on immunocompromised mice and its anti-H1N1 influenza virus effect. Methods To observe the immunomodulatory effect of Kanggan Decoction on immunocompromised mice via the following tests as the reticuloendothelial system phagocytosis test(non-specific immunity),serum hemolysin production test(humoral immunity),delayed hypersensitivity test(cellular immunity)and immune factor regulation test. The protective effect of anti-H1N1 influenza virus was observed by the protective test of drugs on the death of BALB/C mice infected with influenza virus. Results Compared with the model group,the phagocytic ability of the reticuloendothelial system of the mice in each administration group tended to increase,and the difference between the Yupingfeng Granule (玉屏风颗粒)group(1.95 g/kg)and the pidotimod group(0.21 g/kg) was statistically significant(P<0.05 or P<0.01). Compared with the model group,the OD value of serum hemolysin production in each administration group showed an increasing trend,among which the high-dose group of Kanggan Decoction(27.30 g crude drug/kg)and the pidotimod group(0.21 g/kg)increased significantly(P<0.05 or P<0.01). Compared with the model group,the delayed hypersensitivity of mice in each administration group showed a downward trend,among which the low-dose group of Kanggan Decoction(6.82 g crude drug/kg),high dose group(27.30 g crude drug/kg),pidotimod group(0.21 g/kg)decreased significantly(P<0.05 or P<0.01). Compared with the model control group,the high dose group(27.30 g crude drug/kg),Yupingfeng Granule group(1.95 g/kg)and pidotimod group(0.21 g/kg)could promote the secretion of IL-4(P<0.05 or P<0.01),the high dose group(27.30 g crude drug/kg)and pidotimod group(0.21 g/kg)could promote the secretion of IFN-γ(P<0.01,P<0.05),and the high dose group(27.30 g crude drug/kg)could inhibit the secretion of TNF-α(P<0.05). Compared with the model group,the average survival days of the medium dose group(13.65 g crude drug/kg)and the oseltamivir capsule group(19.50 mg/kg)were prolonged(P<0.05 or P<0.01). Conclusion Kanggan Decoction has the effect of improving immunity and anti-H1N1 influenza virus,and its mechanism may be related to promoting the secretion of IL-4 and IFN-γ and inhibiting the production of TNF-α.
[1] FRASER C,DONNELLY CA,CAUCHEMEZ S,et al. Pandemic potential of a strain of influenza A(H1N1):early findings[J].Science,2009,324(5934):1557-1561.
[2]中国研究型医院学会感染与炎症放射学专业委员会,中华医学会放射学分会传染病学组,中国科技产业化促进会数字健康专业委员会,等.甲型H1N1流感重症肺炎影像诊断中国专家共识[J].中华医学杂志,2023,103(33):2571-2578.
[3] GORAYA MU,ZAIGHUM F,SAJJAD N,et al. Web of interferon stimulated antiviral factors to control the influenza A viruses replication[J]. Microb Pathog,2020,139:103919.
[4]陈智.金银花和黄芩不同煎煮方式化学成分变化及抗病毒作用比较[J].中华中医药杂志,2019,34(10):4575-4579.
[5]李仪奎.中药药理实验方法学[M]. 2版.上海:上海科学技术出版社,2006:723-724.
[6]徐叔云.药理实验方法学[M].北京:人民卫生出版社,1982:954.
[7]于新慧,孙延斌,徐晓焱.苦丁茶对免疫功能低下小鼠的实验研究[J].牡丹江医学院学报,2008,29(3):14-16.
[8]魏伟,吴希美,李元建.药理实验方法学[M].北京:人民卫生出版社,2012:1501.
[9]陈鸿珊,张兴权.抗病毒药物及其研究方法[M]. 2版.北京:化学工业出版社,2013:678.
[10] PLESCHKA S. Overview of influenza viruses[J]. Curr Top Microbiol Immunol,2013,370:1-20.
[11] LI H,CAO B. Pandemic and avian influenza a viruses in humans:epidemiology,virology,clinical characteristics,and treatment strategy[J]. Clin Chest Med,2017,38(1):59-70.
[12] Chinese Center for Disease Control and Prevention.中国流感疫苗预防接种技术指南(2019—2020)[J].中国病毒病杂志,2019,9(6):419-428.
[13]蔡超.中医药治疗高危人群流感的临床实效分析[D].北京:中国中医科学院,2016.
[14]罗美.古今名医方论[M].李顺保,薛媛,校注.北京:学苑出版社,2013.
[15]朱晓奕,洪庆,徐卫东,等.玉屏风散及原药材免疫调节活性研究进展[J].亚太传统医药,2017,13(9):66-68.
[16]黄树凌,吴晖.小柴胡汤治疗外感热病(邪郁少阳证)的临床研究[J].临床医学工程,2024,31(1):57-58.
[17]王汉,王敦方,宋红新,等.从《伤寒论》六经辨证探讨抗新冠肺炎“清肺排毒汤”的组方规律[J].海南医学院学报,2020,26(19):1441-1445,1454.
[18]国家卫生健康委,国家中医药管理局.流行性感冒诊疗方案(2020年版)[J].中国病毒病杂志,2021,11(1):1-5.
[19]祝味菊.伤寒质难[M].北京:学苑出版社,2011:185.
[20]王涛,戴明珠,李延川,等.复方中药提取物增强免疫力作用及初步机制研究[J].中国实验动物学报,2022,30(2):198-207.
[21]马文萱.红参复合物清膏增强小鼠免疫力功能的研究[D].长春:吉林大学,2023.
[22]乔东良.支炎合剂对支原体肺炎大鼠IFN-γ、IL-4的影响[D].长沙:湖南中医药大学,2020.
[23] MA T T,LI C,ZHAO F Q,et al. Effects of co-fermented collagen peptide-jackfruit juice on the immune response and gut microbiota in immunosuppressed mice[J]. Food Chem,2021,365:130487.
[24] CHEN X L,CAI B Y,WANG J,et al. Mulberry leaf-derived polysaccharide modulates the immune response and gut microbiota composition in immunocompromised mice[J].Journal of Functional Foods,2021,83(25):104545.
基本信息:
DOI:10.13194/j.issn.1673-842X.2025.07.003
中图分类号:R285.5
引用信息:
[1]王祺,白长川,于雪峰等.抗感方对实验小鼠免疫调节及抗H1N1流感病毒作用探究[J].辽宁中医药大学学报,2025,27(07):10-15.DOI:10.13194/j.issn.1673-842X.2025.07.003.
基金信息:
中医药防治新冠肺炎科研应急攻关专项计划项目(2022OTH007); 国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号)